Gene · 4477
Papers2,399
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,399
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new preparation method of covalent annular nanodiscs based on MTGase. | Arch Biochem Biophys | 2024 | 38621443 | PubTator, text mining | PubMed |
| Phosphorylation of ELYS promotes its interaction with VAPB at decondensing chromosomes during mitosis. | EMBO Rep | 2024 | 38605278 | PubTator, text mining | PubMed |
| Cytochrome P450 genes expression in human prostate cancer. | Mol Genet Metab Rep | 2024 | 38469085 | PubTator, text mining | PubMed |
| Unraveling the transcriptome profile of pulsed electromagnetic field stimulation in bone regeneration using a bioreactor-based investigation platform. | Bone | 2024 | 38428556 | PubTator, text mining | PubMed |
| Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis. | Genome Med | 2024 | 38297291 | PubTator, text mining | PubMed |
| Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases. | Acta Neuropathol | 2024 | 38280071 | PubTator, text mining | PubMed |
| Advances in Sjögren's Syndrome Dry Eye Diagnostics: Biomarkers and Biomolecules beyond Clinical Symptoms. | Biomolecules | 2024 | 38254680 | PubTator, text mining | PubMed |
| MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer. | Transl Oncol | 2024 | 38235618 | PubTator, text mining | PubMed |
| Molecular and evolutionary mechanisms of self-incompatibility in angiosperms. | Yi Chuan | 2024 | 38230453 | PubTator, text mining | PubMed |
| Disentangling brain PrPC proteoforms and their roles in physiology and disease. | Neural Regen Res | 2024 | 37862190 | PubTator, text mining | PubMed |
| Direct stimulation of de novo nucleotide synthesis by O-GlcNAcylation. | Nat Chem Biol | 2024 | 37308732 | PubTator, text mining | PubMed |
| Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2. | Curr Res Chem Biol | 2023 | 41883516 | PubTator, text mining | PubMed |
| Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer. | J Immunother Cancer | 2023 | 38101860 | PubTator, text mining | PubMed |
| [Review of a series of cases of Creutzfeldt-Jakob disease in a tertiary care hospital]. | Rev Neurol | 2023 | 38095054 | PubTator, text mining | PubMed |
| A new approach to prostate cancer screening. | Adv Lab Med | 2023 | 38075179 | PubTator, text mining | PubMed |
| Melamine-cored glucosides for membrane protein solubilization and stabilization: importance of water-mediated intermolecular hydrogen bonding in detergent performance. | Chem Sci | 2023 | 38023530 | PubTator, text mining | PubMed |
| Circularized Nanodiscs for Multivalent Mosaic Display of SARS-CoV-2 Spike Protein Antigens. | Vaccines (Basel) | 2023 | 38005987 | PubTator, text mining | PubMed |
| Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems. | Pharmaceutics | 2023 | 38004601 | PubTator, text mining | PubMed |
| Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer. | Cancers (Basel) | 2023 | 38001678 | PubTator, text mining | PubMed |
| Accurate digital quantification of tau pathology in progressive supranuclear palsy. | Acta Neuropathol Commun | 2023 | 37946288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4477/papers?page=4